Actuated Medical Obtains FDA Clearance for TubeClear, a System That Clears Patient Feeding and Decompression Tubes

Actuated Medical Obtains FDA Clearance for TubeClear, a System That Clears Patient Feeding and Decompression Tubes

<0> Actuated Medical, Inc.Maureen L. Mulvihill, Ph.D., 814-355-0003 </0>

Today, Actuated Medical, Inc. announced that the U.S. Food and Drug Administration (FDA) determined substantial equivalence of AMI’s TubeClear™ system specific to nasogastric (NG) feeding and decompression tubes.

TubeClear uses Actuated Medical’s proprietary mechanical motion technology to clear clogs in NG tubes. Clearing NG tubes prevents disruptions in feeding and medication delivery and allows clinicians to maintain their focus on improving patient care. The system, which is comprised of reusable control boxes and single-use clearing stems, is designed, developed, and manufactured by Actuated Medical in the United States.

Maureen L. Mulvihill, Ph.D., President of Actuated Medical, commented that, “Clogging is a significant problem occurring in approximately 25% of feeding and decompression tubes. Our TubeClear system has proven to be both fast and consistently effective. In fact, our studies show it to be at least seven times faster than current approaches. It allows caregivers to quickly reinstate feeding and medication regimens without removing and replacing tubes. In this new era of healthcare cost containment, it will certainly help organizations save significant time and money.”

In addition to the newly approved system for NG tubes, two new TubeClear control boxes as well as clearing tubes for Nasoenteric (nENT), Percutaneous Endoscopic Gastronomy (PEG) and Gastrostomy-Jejunostomy (GJ) tubes are currently pending 510(k) clearance with the FDA.

TubeClear is also CE Marked and is available throughout Europe, the Middle East and North Africa.

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.